Top Markets
#1 Bedrock Bedrock +34.97%
#2 Naoris Protocol Naoris Protocol +26.67%
#3 IQ IQ +17.63%
#4 pippin pippin +17.29%
#5 Bitway Bitway +17.15%
#6 Irys Irys +15.35%
#7 peaq peaq +10.50%
#8 Chrema Coin Chrema Coin +10.12%
#9 XPLA XPLA +10.05%
#10 ETHGas ETHGas +8.06%
Coin of the day
Bedrock Bedrock
Settings
Language
ENGLISH
Currency
USD
Theme
Fusion Antibodies plc Fusion Antibodies plc

Fusion Antibodies plc

FAB
Rank in Stocks #20441
Fusion Antibodies plc, a contract research organization, engages in the... Fusion Antibodies plc, a contract research organization, engages in the research, development, and manufacture of recombinant proteins and antibodies primarily for cancer and infectious diseases in the United Kingdom, the rest of Europe, North America, and internationally. It offers monoclonal antibody discovery and development, antibody sequencing, antibody engineering, antibody humanization and rational affinity maturation platform, recombinant protein expression, and stable cell line development and cGMP scale up services. The company serves pharmaceutical, biotech, and diagnostic companies. It has a collaboration partnership with Celonic AG. Fusion Antibodies plc was incorporated in 2000 and is headquartered in Belfast, the United Kingdom.
Share Price
$0.16328419
Market Cap
$204.14K
Change (1 day)
4.35%
Change (1 year)
102.45%
Country
GB
Trade Fusion Antibodies plc (FAB)

Category

Healthcare
Operating Margin for Fusion Antibodies plc (FAB)
Operating Margin as of March 2026 TTM: -118.73%
According to Fusion Antibodies plc latest financial reports and stock price the company's current Operating Margin (TTM) is -118.73%. At the end of 2024 the company had an Operating Margin of -201.41%.
Operating Margin history for Fusion Antibodies plc from 2013 to 2026
Operating Margin at the end of each year
Year Operating Margin Change
2026 (TTM) -118.73% 31.15%
2025 -90.53% -55.05%
2024 -201.41% 106.24%
2023 -97.66% 251.80%
2022 -27.76% -16.16%
2021 -33.11% 15.77%
2020 -28.60% -58.63%
2019 -69.14% -3,080.17%
2018 2.32% -64.90%
2017 6.61% 253.48%
2016 1.87% -117.22%
2015 -10.86% -34.26%
2014 -16.52% -85.86%
2013 -116.84% 0.00%
Operating Margin for similar companies or competitors
Company Operating Margin Operating Margin Difference Country
Novo Nordisk A/S Novo Nordisk A/S
Novo Nordisk A/S
NVO.US
41.30% -100.35%
DK
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
35.45% -100.30%
US
Regeneron Pharmaceuticals, Inc. Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
REGN.US
24.95% -100.21%
US
UCB SA UCB SA
UCB SA
UCB.BR
25.32% -100.21%
BE
Argenx SE Argenx SE
Argenx SE
ARGX.US
25.64% -100.22%
NL
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.